REPORT OUTLOOK
Market Size | CAGR | Dominating Region |
---|---|---|
USD 8.40 billion by 2030 | 10.3% | Asia Pacific |
by Product | by Technology | by Application |
---|---|---|
|
|
|
SCOPE OF THE REPORT
Neuroscience Antibodies & Assays Market Overview
Neuroscience antibodies & assays market is expected to grow at 10.3% CAGR from 2023 To 2030. It was valued 4.23 billion at 2023. It is expected to reach above USD 8.40 billion by 2030.
The market for neuroscience antibodies and tests is predicted to rise as a result of reasons including the rising prevalence of neurological illnesses, expanding biotech and pharmaceutical sectors, and rising funding for brain research.
The biotechnology business has a segment called “Neuroscience Antibodies and Assays Market” that focuses on creating and selling goods that help with nervous system research. The need for neuroscience research to better comprehend the intricacies of the brain and nervous system is what is driving this market. In order to detect, localize, and quantify particular chemicals and structures within the nervous system, neuroscience assays and antibodies are essential to this research.
Neuroscience antibodies are proteins that have the ability to recognize and attach to particular molecules or components of the nervous system, such as receptors, ion channels, and neurotransmitters. Numerous procedures, including as immunohistochemistry, western blotting, and enzyme-linked immunosorbent assays (ELISA), utilize these antibodies. Biochemical tests called “neuroscience assays” assess the quantity or activity of particular substances in the nervous system, such as neurotransmitters, cytokines, and growth hormones. These tests are used to identify changes in the nervous system caused by a variety of factors, such as disease, ageing, or developmental changes.
Since neurological illnesses including Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis are becoming more and more common, the market for neuroscience antibodies and assays is anticipated to expand dramatically over the upcoming years. The need for neuroscience antibodies and assays is also anticipated to increase as a result of technological advancements like CRISPR/Cas9 gene editing and ontogenetic. The demand for efficient treatments for neurological illnesses is driving continuing expansion and innovation in the market for neuroscience antibodies and assays.
The market for neuroscience antibodies and assays is primarily driven by a number of important factors, such as the rise in neurological illnesses, the rising interest in neuroscience research, and the creation of cutting-edge tools for understanding the nervous system. The market is also being impacted by rising investments in research and development, partnerships and collaborations, as well as mergers and acquisitions among major players in the sector.
The market is confronted with a number of difficulties, including the high cost of neuroscience research, the complicated regulatory environment, and the absence of standards for tests and antibodies. The market is also very competitive, with a lot of firms seeking for a piece of the expanding demand. Companies in the Neuroscience Antibodies & Assays Market are concentrating on creating cutting-edge goods, increasing their geographic reach, and establishing strategic alliances and collaborations with other businesses and research institutions in order to stay competitive.
ATTRIBUTE | DETAILS |
Study period | 2020-2030 |
Base year | 2022 |
Estimated year | 2023 |
Forecasted year | 2023-2030 |
Historical period | 2019-2021 |
Unit | Value (USD Billion, Thousand Units) |
Segmentation | By Product, By Technology, By Application, By End user |
By Product |
|
By Technology |
|
By Application |
|
By End user |
|
By Region |
|
Neuroscience Antibodies & Assays Market Segment Analysis
By product the market is segmented into consumables, instruments. Consumables, such as antibodies, assay kits, and reagents, are crucial elements in neuroscience research as they allow for the identification, localization, and measurement of certain molecules and nervous system structures. Due to the rising incidence of neurological illnesses and the expanding demand for neuroscience research, these consumables are in great demand. In order to analyze and visualize molecular and cellular structures in the nervous system, instruments like microscopes, flow cytometers, and spectrophotometers are also crucial in neuroscience research. The need for these tools is expanding as a result of technological advancements and the complexity of neuroscience research, both of which need for increasingly advanced and specialized equipment. The market for neuroscience antibodies & assays is expanding due to the combination of consumables and equipment.
By technology the market is segmented into clinical chemistry, immunochemistry, molecular diagnostics, other technologies. Immunochemistry is the most widely used technology in the neuroscience antibodies and assays market, accounting for 60% of the market share. This is because immunochemical assays are highly sensitive and specific, making them ideal for detecting and measuring a wide range of neuroscience targets. With the aid of these technologies, specific chemicals, proteins, and genetic components of the nervous system can be found and measured. These technologies are utilised in a number of processes, such as diagnostics, drug discovery, and biomarker identification. Neurological illnesses including Alzheimer’s and Parkinson’s disease are frequently diagnosed and monitored using clinical chemistry and immunochemistry, which gives doctors vital information about their patients’ situations. On the other hand, molecular diagnostics allow for the discovery of genetic mutations and variations that can result in neurological illnesses, assisting in the identification of individuals who are at risk and directing personalized treatment strategies.
By application the market is segmented into drug discovery & development, research, in vitro diagnostics. The need for medication research and development is fueled by the rising prevalence of neurological illnesses and the increasing need for effective therapies. In these endeavors, neuroscience antibodies and assays are essential as they give researchers the instruments they need to identify and validate therapeutic targets, screen novel molecules, and keep track of the effectiveness and safety of medications. Additionally, the application of neuroscience assays and antibodies in research settings offers important insights into the underlying mechanisms of neurological illnesses, spurring advancement in the discipline. The market’s participation in in vitro diagnostics is also growing, allowing medical professionals to detect and track neurological problems more successfully, fueling additional market expansion.
By end user the market is segmented into hospitals & diagnostics centers, pharmaceutical & biotechnology companies, academic & research institutes. The market for these items is fueled by the use of neuroscience antibodies and assays in these institutions’ research, drug development, and in vitro diagnostics. Additionally, the pharmaceutical and biotechnology industries, which make up the largest customer category, count these universities among their most important clients. Collaboration between these organizations and key market participant’s fosters innovation and further market expansion.
Neuroscience Antibodies & Assays Market Key Players
Neuroscience antibodies & assays market key players include Cell Signalling Technology, Genscript, Rockland Immunochemicals, BioLegend, Santa Cruz Biotechnology, Roche, Siemens, Thermo Fisher Scientific, Abcam, Bio-Rad.
Recent News:
February 14, 2023:Â Bio-Techne and Cell Signaling Technology announced partnership to validate Simple Western antibodies.
March 28, 2023: GenScript Entered into a Strategic Collaboration Agreement with PersonGen on Cell Isolation Products.
Who Should Buy? Or Key stakeholders
- Academic institutes
- Pharmaceutical companies
- Hospitals and diagnostics centers
- Healthcare providers
- Contract research organizations
- Neuroscience associations
- Patients
- Government agencies
- Research organizations
- Others
Neuroscience Antibodies & Assays Market Regional Analysis
Neuroscience antibodies & assays market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
- North America: includes the US, Canada, Mexico
- Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
- Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
- South America: includes Brazil, Argentina and Rest of South America
- Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA
Due to factors like the rising prevalence of neurological disorders, the rising demand for neuroscience research, and the presence of several major players in the market, North America is a significant market for neuroscience antibodies and assays. The demand for neuroscience antibodies and assays is mostly driven by the US, which accounts for the greatest share of the North American market. This is due to the nation’s enormous investments in research and development as well as the accessibility of cutting-edge technologies. The development of the Neuroscience Antibodies & Assays Market in North America is also aided by the region’s developed healthcare infrastructure and high prevalence of public awareness of neurological illnesses.
Key Market Segments: Neuroscience Antibodies & Assays Market
Neuroscience Antibodies & Assays Market by Product, 2020-2030, (USD Billion, Thousand Units)
- Consumables
- Instruments
Neuroscience Antibodies & Assays Market by Technology, 2020-2030, (USD Billion, Thousand Units)
- Clinical Chemistry
- Immunochemistry
- Molecular Diagnostics
- Other Technologies
Neuroscience Antibodies & Assays Market by Application, 2020-2030, (USD Billion, Thousand Units)
- Drug Discovery & Development
- Research
- In Vitro Diagnostics
Neuroscience Antibodies & Assays Market by End User, 2020-2030, (USD Billion, Thousand Units)
- Hospitals & Diagnostics Centers
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
Neuroscience Antibodies & Assays Market by Region, 2020-2030, (USD Billion, Thousand Units)
- North America
- Asia Pacific
- Europe
- South America
- Middle East and Africa
Important Countries in All Regions Are Covered.
Exactitude Consultancy Services Key Objectives:
- Increasing sales and market share
- Developing new Application
- Improving profitability
- Entering new markets
- Enhancing brand reputation
Key Question Answered
- What is the expected growth rate of the neuroscience antibodies & assays market over the next 7 years?
- Who are the major players in the neuroscience antibodies & assays market and what is their market share?
- What are the end-user industries driving demand for market and what is their outlook?
- What are the opportunities for growth in emerging markets such as asia-pacific, middle east, and africa?
- How is the economic environment affecting the neuroscience antibodies & assays market, including factors such as interest rates, inflation, and exchange rates?
- What is the expected impact of government policies and regulations on the neuroscience antibodies & assays market?
- What is the current and forecasted size and growth rate of the global neuroscience antibodies & assays market?
- What are the key drivers of growth in the neuroscience antibodies & assays market?
- Who are the major players in the market and what is their market share?
- What are the distribution channels and supply chain dynamics in the neuroscience antibodies & assays market?
- What are the technological advancements and innovations in the neuroscience antibodies & assays market and their impact on product development and growth?
- What are the regulatory considerations and their impact on the market?
- What are the challenges faced by players in the neuroscience antibodies & assays market and how are they addressing these challenges?
- What are the opportunities for growth and expansion in the neuroscience antibodies & assays market?
- What are the product offerings and specifications of leading players in the market?
- What is the pricing trend of neuroscience antibodies & assays market in the market and what is the impact of raw material prices on the price trend?
Table of Content
- INTRODUCTION
- MARKET DEFINITION
- MARKET SEGMENTATION
- RESEARCH TIMELINES
- ASSUMPTIONS AND LIMITATIONS
- RESEARCH METHODOLOGY
- DATA MINING
- SECONDARY RESEARCH
- PRIMARY RESEARCH
- SUBJECT-MATTER EXPERTS’ ADVICE
- QUALITY CHECKS
- FINAL REVIEW
- DATA TRIANGULATION
- BOTTOM-UP APPROACH
- TOP-DOWN APPROACH
- RESEARCH FLOW
- DATA SOURCES
- DATA MINING
- EXECUTIVE SUMMARY
- MARKET OVERVIEW
- GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET OUTLOOK
- MARKET DRIVERS
- MARKET RESTRAINTS
- MARKET OPPORTUNITIES
- IMPACT OF COVID-19 ON NEUROSCIENCE ANTIBODIES & ASSAYS MARKET
- PORTER’S FIVE FORCES MODEL
- THREAT FROM NEW ENTRANTS
- THREAT FROM SUBSTITUTES
- BARGAINING POWER OF SUPPLIERS
- BARGAINING POWER OF CUSTOMERS
- DEGREE OF COMPETITION
- INDUSTRY VALUE CHAIN ANALYSIS
- GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET OUTLOOK
- GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (USD BILLION, THOUSAND UNITS), 2020-2030
- CONSUMABLES
- INSTRUMENTS
- GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (USD BILLION, THOUSAND UNITS), 2020-2030
- CLINICAL CHEMISTRY
- IMMUNOCHEMISTRY
- MOLECULAR DIAGNOSTICS
- OTHER TECHNOLOGIES
- GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (USD BILLION, THOUSAND UNITS), 2020-2030
- DRUG DISCOVERY & DEVELOPMENT
- RESEARCH
- IN VITRO DIAGNOSTICS
- GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (USD BILLION, THOUSAND UNITS), 2020-2030
- HOSPITALS & DIAGNOSTICS CENTERS
- PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- ACADEMIC & RESEARCH INSTITUTES
- GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY REGION (USD BILLION, THOUSAND UNITS), 2020-2030
- NORTH AMERICA
- US
- CANADA
- MEXICO
- SOUTH AMERICA
- BRAZIL
- ARGENTINA
- COLOMBIA
- REST OF SOUTH AMERICA
- EUROPE
- GERMANY
- UK
- FRANCE
- ITALY
- SPAIN
- RUSSIA
- REST OF EUROPE
- ASIA PACIFIC
- INDIA
- CHINA
- JAPAN
- SOUTH KOREA
- AUSTRALIA
- SOUTH-EAST ASIA
- REST OF ASIA PACIFIC
- MIDDLE EAST AND AFRICA
- UAE
- SAUDI ARABIA
- SOUTH AFRICA
- REST OF MIDDLE EAST AND AFRICA
- NORTH AMERICA
- COMPANY PROFILES*
(BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCTS OFFERED, RECENT DEVELOPMENTS)
- CELL SIGNALLING TECHNOLOGY
- GENSCRIPT
- ROCKLAND IMMUNOCHEMICALS
- BIOLEGEND
- SANTA CRUZ BIOTECHNOLOGY
- ROCHE
- SIEMENS
- THERMO FISHER SCIENTIFIC
- ABCAM
- BIO-RAD
*THE COMPANY LIST IS INDICATIVE
 LIST OF TABLES
TABLE 1 GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 2 GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (THOUSAND UNITS) 2020-2030
TABLE 3 GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (USD BILLION) 2020-2030
TABLE 4 GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (THOUSAND UNITS) 2020-2030
TABLE 5 GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 6 GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 7 GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 8 GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 9 GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY REGION (USD BILLION) 2020-2030
TABLE 10 GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY REGION (THOUSAND UNITS) 2020-2030
TABLE 11 NORTH AMERICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY COUNTRY (USD BILLION) 2020-2030
TABLE 12 NORTH AMERICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY COUNTRY (THOUSAND UNITS) 2020-2030
TABLE 13 NORTH AMERICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 14 NORTH AMERICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (THOUSAND UNITS) 2020-2030
TABLE 15 NORTH AMERICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (USD BILLION) 2020-2030
TABLE 16 NORTH AMERICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (THOUSAND UNITS) 2020-2030
TABLE 17 NORTH AMERICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 18 NORTH AMERICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 19 NORTH AMERICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 20 NORTH AMERICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 21 US NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 22 US NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (THOUSAND UNITS) 2020-2030
TABLE 23 US NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (USD BILLION) 2020-2030
TABLE 24 US NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (THOUSAND UNITS) 2020-2030
TABLE 25 US NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 26 US NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 27 US NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 28 US NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 29 CANADA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 30 CANADA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (THOUSAND UNITS) 2020-2030
TABLE 31 CANADA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (USD BILLION) 2020-2030
TABLE 32 CANADA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (THOUSAND UNITS) 2020-2030
TABLE 33 CANADA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 34 CANADA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 35 CANADA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 36 CANADA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 37 MEXICO NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 38 MEXICO NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (THOUSAND UNITS) 2020-2030
TABLE 39 MEXICO NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (USD BILLION) 2020-2030
TABLE 40 MEXICO NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (THOUSAND UNITS) 2020-2030
TABLE 41 MEXICO NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 42 MEXICO NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 43 MEXICO NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 44 MEXICO NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 45 SOUTH AMERICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY COUNTRY (USD BILLION) 2020-2030
TABLE 46 SOUTH AMERICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY COUNTRY (THOUSAND UNITS) 2020-2030
TABLE 47 SOUTH AMERICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 48 SOUTH AMERICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (THOUSAND UNITS) 2020-2030
TABLE 49 SOUTH AMERICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (USD BILLION) 2020-2030
TABLE 50 SOUTH AMERICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (THOUSAND UNITS) 2020-2030
TABLE 51 SOUTH AMERICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 52 SOUTH AMERICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 53 SOUTH AMERICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 54 SOUTH AMERICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 55 BRAZIL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 56 BRAZIL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (THOUSAND UNITS) 2020-2030
TABLE 57 BRAZIL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (USD BILLION) 2020-2030
TABLE 58 BRAZIL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (THOUSAND UNITS) 2020-2030
TABLE 59 BRAZIL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 60 BRAZIL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 61 BRAZIL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 62 BRAZIL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 63 ARGENTINA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 64 ARGENTINA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (THOUSAND UNITS) 2020-2030
TABLE 65 ARGENTINA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (USD BILLION) 2020-2030
TABLE 66 ARGENTINA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (THOUSAND UNITS) 2020-2030
TABLE 67 ARGENTINA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 68 ARGENTINA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 69 ARGENTINA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 70 ARGENTINA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 71 COLOMBIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 72 COLOMBIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (THOUSAND UNITS) 2020-2030
TABLE 73 COLOMBIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (USD BILLION) 2020-2030
TABLE 74 COLOMBIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (THOUSAND UNITS) 2020-2030
TABLE 75 COLOMBIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 76 COLOMBIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 77 COLOMBIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 78 COLOMBIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 79 REST OF SOUTH AMERICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 80 REST OF SOUTH AMERICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (THOUSAND UNITS) 2020-2030
TABLE 81 REST OF SOUTH AMERICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (USD BILLION) 2020-2030
TABLE 82 REST OF SOUTH AMERICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (THOUSAND UNITS) 2020-2030
TABLE 83 REST OF SOUTH AMERICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 84 REST OF SOUTH AMERICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 85 REST OF SOUTH AMERICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 86 REST OF SOUTH AMERICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 87 ASIA-PACIFIC NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY COUNTRY (USD BILLION) 2020-2030
TABLE 88 ASIA-PACIFIC NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY COUNTRY (THOUSAND UNITS) 2020-2030
TABLE 89 ASIA-PACIFIC NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 90 ASIA-PACIFIC NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (THOUSAND UNITS) 2020-2030
TABLE 91 ASIA-PACIFIC NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (USD BILLION) 2020-2030
TABLE 92 ASIA-PACIFIC NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (THOUSAND UNITS) 2020-2030
TABLE 93 ASIA-PACIFIC NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 94 ASIA-PACIFIC NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 95 ASIA-PACIFIC NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 96 ASIA-PACIFIC NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 97 INDIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 98 INDIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (THOUSAND UNITS) 2020-2030
TABLE 99 INDIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (USD BILLION) 2020-2030
TABLE 100 INDIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (THOUSAND UNITS) 2020-2030
TABLE 101 INDIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 102 INDIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 103 INDIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 104 INDIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 105 CHINA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 106 CHINA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (THOUSAND UNITS) 2020-2030
TABLE 107 CHINA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (USD BILLION) 2020-2030
TABLE 108 CHINA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (THOUSAND UNITS) 2020-2030
TABLE 109 CHINA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 110 CHINA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 111 CHINA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 112 CHINA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 113 JAPAN NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 114 JAPAN NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (THOUSAND UNITS) 2020-2030
TABLE 115 JAPAN NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (USD BILLION) 2020-2030
TABLE 116 JAPAN NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (THOUSAND UNITS) 2020-2030
TABLE 117 JAPAN NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 118 JAPAN NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 119 JAPAN NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 120 JAPAN NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 121 SOUTH KOREA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 122 SOUTH KOREA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (THOUSAND UNITS) 2020-2030
TABLE 123 SOUTH KOREA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (USD BILLION) 2020-2030
TABLE 124 SOUTH KOREA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (THOUSAND UNITS) 2020-2030
TABLE 125 SOUTH KOREA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 126 SOUTH KOREA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 127 SOUTH KOREA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 128 SOUTH KOREA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 129 AUSTRALIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 130 AUSTRALIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (THOUSAND UNITS) 2020-2030
TABLE 131 AUSTRALIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (USD BILLION) 2020-2030
TABLE 132 AUSTRALIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (THOUSAND UNITS) 2020-2030
TABLE 133 AUSTRALIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 134 AUSTRALIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 135 AUSTRALIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 136 AUSTRALIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 137 SOUTH-EAST ASIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 138 SOUTH-EAST ASIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (THOUSAND UNITS) 2020-2030
TABLE 139 SOUTH-EAST ASIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (USD BILLION) 2020-2030
TABLE 140 SOUTH-EAST ASIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (THOUSAND UNITS) 2020-2030
TABLE 141 SOUTH-EAST ASIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 142 SOUTH-EAST ASIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 143 SOUTH-EAST ASIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 144 SOUTH-EAST ASIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 145 REST OF ASIA PACIFIC NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 146 REST OF ASIA PACIFIC NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (THOUSAND UNITS) 2020-2030
TABLE 147 REST OF ASIA PACIFIC NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (USD BILLION) 2020-2030
TABLE 148 REST OF ASIA PACIFIC NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (THOUSAND UNITS) 2020-2030
TABLE 149 REST OF ASIA PACIFIC NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 150 REST OF ASIA PACIFIC NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 151 REST OF ASIA PACIFIC NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 152 REST OF ASIA PACIFIC NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 153 EUROPE NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY COUNTRY (USD BILLION) 2020-2030
TABLE 154 EUROPE NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY COUNTRY (THOUSAND UNITS) 2020-2030
TABLE 155 EUROPE NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 156 EUROPE NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (THOUSAND UNITS) 2020-2030
TABLE 157 EUROPE NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (USD BILLION) 2020-2030
TABLE 158 EUROPE NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (THOUSAND UNITS) 2020-2030
TABLE 159 EUROPE NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 160 EUROPE NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 161 EUROPE NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 162 EUROPE NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 163 GERMANY NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 164 GERMANY NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (THOUSAND UNITS) 2020-2030
TABLE 165 GERMANY NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (USD BILLION) 2020-2030
TABLE 166 GERMANY NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (THOUSAND UNITS) 2020-2030
TABLE 167 GERMANY NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 168 GERMANY NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 169 GERMANY NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 170 GERMANY NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 171 UK NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 172 UK NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (THOUSAND UNITS) 2020-2030
TABLE 173 UK NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (USD BILLION) 2020-2030
TABLE 174 UK NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (THOUSAND UNITS) 2020-2030
TABLE 175 UK NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 176 UK NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 177 UK NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 178 UK NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 179 FRANCE NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 180 FRANCE NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (THOUSAND UNITS) 2020-2030
TABLE 181 FRANCE NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (USD BILLION) 2020-2030
TABLE 182 FRANCE NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (THOUSAND UNITS) 2020-2030
TABLE 183 FRANCE NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 184 FRANCE NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 185 FRANCE NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 186 FRANCE NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 187 ITALY NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 188 ITALY NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (THOUSAND UNITS) 2020-2030
TABLE 189 ITALY NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (USD BILLION) 2020-2030
TABLE 190 ITALY NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (THOUSAND UNITS) 2020-2030
TABLE 191 ITALY NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 192 ITALY NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 193 ITALY NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 194 ITALY NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 195 SPAIN NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 196 SPAIN NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (THOUSAND UNITS) 2020-2030
TABLE 197 SPAIN NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (USD BILLION) 2020-2030
TABLE 198 SPAIN NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (THOUSAND UNITS) 2020-2030
TABLE 199 SPAIN NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 200 SPAIN NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 201 SPAIN NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 202 SPAIN NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 203 RUSSIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 204 RUSSIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (THOUSAND UNITS) 2020-2030
TABLE 205 RUSSIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (USD BILLION) 2020-2030
TABLE 206 RUSSIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (THOUSAND UNITS) 2020-2030
TABLE 207 RUSSIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 208 RUSSIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 209 RUSSIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 210 RUSSIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 211 REST OF EUROPE NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 212 REST OF EUROPE NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (THOUSAND UNITS) 2020-2030
TABLE 213 REST OF EUROPE NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (USD BILLION) 2020-2030
TABLE 214 REST OF EUROPE NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (THOUSAND UNITS) 2020-2030
TABLE 215 REST OF EUROPE NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 216 REST OF EUROPE NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 217 REST OF EUROPE NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 218 REST OF EUROPE NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 219 MIDDLE EAST AND AFRICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY COUNTRY (USD BILLION) 2020-2030
TABLE 220 MIDDLE EAST AND AFRICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY COUNTRY (THOUSAND UNITS) 2020-2030
TABLE 221 MIDDLE EAST AND AFRICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 222 MIDDLE EAST AND AFRICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (THOUSAND UNITS) 2020-2030
TABLE 223 MIDDLE EAST AND AFRICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (USD BILLION) 2020-2030
TABLE 224 MIDDLE EAST AND AFRICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (THOUSAND UNITS) 2020-2030
TABLE 225 MIDDLE EAST AND AFRICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 226 MIDDLE EAST AND AFRICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 227 MIDDLE EAST AND AFRICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 228 MIDDLE EAST AND AFRICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 229 UAE NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 230 UAE NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (THOUSAND UNITS) 2020-2030
TABLE 231 UAE NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (USD BILLION) 2020-2030
TABLE 232 UAE NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (THOUSAND UNITS) 2020-2030
TABLE 233 UAE NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 234 UAE NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 235 UAE NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 236 UAE NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 237 SAUDI ARABIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 238 SAUDI ARABIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (THOUSAND UNITS) 2020-2030
TABLE 239 SAUDI ARABIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (USD BILLION) 2020-2030
TABLE 240 SAUDI ARABIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (THOUSAND UNITS) 2020-2030
TABLE 241 SAUDI ARABIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 242 SAUDI ARABIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 243 SAUDI ARABIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 244 SAUDI ARABIA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 245 SOUTH AFRICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 246 SOUTH AFRICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (THOUSAND UNITS) 2020-2030
TABLE 247 SOUTH AFRICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (USD BILLION) 2020-2030
TABLE 248 SOUTH AFRICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (THOUSAND UNITS) 2020-2030
TABLE 249 SOUTH AFRICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 250 SOUTH AFRICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 251 SOUTH AFRICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 252 SOUTH AFRICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 253 REST OF MIDDLE EAST AND AFRICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 254 REST OF MIDDLE EAST AND AFRICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT (THOUSAND UNITS) 2020-2030
TABLE 255 REST OF MIDDLE EAST AND AFRICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (USD BILLION) 2020-2030
TABLE 256 REST OF MIDDLE EAST AND AFRICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY (THOUSAND UNITS) 2020-2030
TABLE 257 REST OF MIDDLE EAST AND AFRICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 258 REST OF MIDDLE EAST AND AFRICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 259 REST OF MIDDLE EAST AND AFRICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 260 REST OF MIDDLE EAST AND AFRICA NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER (THOUSAND UNITS) 2020-2030
LIST OF FIGURES
FIGURE 1 MARKET DYNAMICS
FIGURE 2 MARKET SEGMENTATION
FIGURE 3 REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4 DATA TRIANGULATION
FIGURE 5 BOTTOM-UP APPROACH
FIGURE 6 TOP-DOWN APPROACH
FIGURE 7 RESEARCH FLOW
FIGURE 8 GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT, USD BILLION, 2020-2030
FIGURE 9 GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY, USD BILLION, 2020-2030
FIGURE 10 GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION, USD BILLION, 2020-2030
FIGURE 11 GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER, USD BILLION, 2020-2030
FIGURE 12 GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY REGION, USD BILLION, 2020-2030
FIGURE 13 PORTER’S FIVE FORCES MODEL
FIGURE 14 GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY PRODUCT, USD BILLION, 2022
FIGURE 15 GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY TECHNOLOGY, USD BILLION, 2022
FIGURE 16 GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY APPLICATION, USD BILLION, 2022
FIGURE 17 GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY END USER, USD BILLION, 2022
FIGURE 18 GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET BY REGION, USD BILLION, 2022
FIGURE 19 MARKET SHARE ANALYSIS
FIGURE 20 CELL SIGNALLING TECHNOLOGY: COMPANY SNAPSHOT
FIGURE 21 GENSCRIPT: COMPANY SNAPSHOT
FIGURE 22 ROCKLAND IMMUNOCHEMICALS: COMPANY SNAPSHOT
FIGURE 23 BIOLEGEND: COMPANY SNAPSHOT
FIGURE 24 SANTA CRUZ BIOTECHNOLOGY: COMPANY SNAPSHOT
FIGURE 25 ROCHE: COMPANY SNAPSHOT
FIGURE 26 SIEMENS: COMPANY SNAPSHOT
FIGURE 27 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
FIGURE 28 ABCAM: COMPANY SNAPSHOT
FIGURE 29 BIO-RAD: COMPANY SNAPSHOT
FAQ
Neuroscience antibodies & assays market is expected to grow at 10.3% CAGR from 2023 To 2030. It was valued 4.23 billion at 2023. It is expected to reach above USD 8.40 billion by 2030.
North America held more than 39% of neuroscience antibodies & assays market revenue share in 2022 and will witness expansion in the forecast period.
The market for neuroscience antibodies and tests is predicted to rise as a result of reasons including the rising prevalence of neurological illnesses, expanding biotech and pharmaceutical sectors, and rising funding for brain research.
The market for end user items is fueled by the use of neuroscience antibodies and assays in these institutions’ research, drug development, and in vitro diagnostics. Additionally, the pharmaceutical and biotechnology industries, which make up the largest customer category, count these universities among their most important clients.
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.